Research News

31 December 2025

New Research Identifies Dihydrotanshinone I as a Potential Therapeutic Agent for Ovarian Cancer by Targeting SORT1

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ovarian cancer. The research, conducted by a team from Zhejiang Chinese Medical University and Jiangsu Normal University, reveals that DHT can induce autophagic cell death in ovarian cancer cells by disrupting the sortilin 1 (SORT1)-mediated autophagy–lysosome pathway.

26 December 2025

New Global Study Questions Tramadol Use for Long-Term Pain Relief

A new large systematic review published this week has raised important questions about the safety and effectiveness of tramadol, a widely prescribed opioid for chronic pain relief. The study, published online ahead of print in BMJ Evidence-Based Medicine, finds that while tramadol does reduce pain compared with placebo, the benefit is small and may not be clinically meaningful for many patients.

26 December 2025

New Hope for Thalassemia Patients as FDA Greenlights Agios’ Aqvesme – But Cautions Remain

A major breakthrough for adults living with rare inherited blood disorders, the U.S. Food and Drug Administration (FDA) has officially approved Agios Pharmaceuticals’ oral drug AQVESME™ (mitapivat) for the treatment of anemia in both alpha- and beta-thalassemia, regardless of whether patients require regular blood transfusions or not.

26 December 2025

Biofabri–Bharat Biotech pact brings fresh hope in global fight against Tuberculosis

Biofabri and Bharat Biotech International Limited have signed a technology transfer agreement aimed at improving worldwide access to the promising TB vaccine candidate, MTBVAC.

24 December 2025

New WHO Report Shows Big Gaps in Global Genomics Research

The World Health Organization (WHO) has come out with a new global analysis that shows there are major equity gaps in human genomics research, especially between rich and poorer countries.

18 December 2025

New antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.

11 December 2025

Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer

Roche announced today positive data from the phase III lidERA Breast Cancer study evaluating investigational giredestrant as an adjuvant endocrine treatment for people with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative, early-stage breast cancer.

8 December 2025

Silicon chips on the brain : Researchers announce a new generation of brain-computer interface

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and blindness – helping to manage seizures and restore motor, speech, and visual function. This is done by providing a minimally invasive, high-throughput information link directly to and from the brain.

8 December 2025

New drug for diabetes and obesity shows promising results

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people with type 2 diabetes and obesity, according to a new study published in the journal Cell by researchers from Karolinska Institutet and Stockholm University.

5 December 2025

Breakthrough in Nerve Repair: Axogen, Inc. Gets FDA Go-Ahead for AVANCE® Nerve Graft

U.S. Food and Drug Administration officially approved a Biologics License Application (BLA) for AVANCE, a processed human nerve scaffold developed by Axogen, for treating peripheral nerve discontinuities in both adults and pediatric patients, including infants aged as young as one month.

Search

New Research Identifies Dihydrotanshinone I as a Potential Therapeutic Agent for Ovarian Cancer by Targeting SORT1

RECOMMENDED POSTS

Subscribe with us

Jobs by Category